Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: Serial cross-sectional surveys

Al Kaabi, 2021, Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial, JAMA, 326, 35, 10.1001/jama.2021.8565 Thomas, 2021, Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months, N Engl J Med, 385, 1761, 10.1056/NEJMoa2110345 Tartof, 2021, Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study, Lancet, 398, 1407, 10.1016/S0140-6736(21)02183-8 Madhi, 2021, Efficacy of the ChAdOx1 nCoV-19 COVID-19 vaccine against the B. 1.351 variant, N Engl J Med, 384, 1885, 10.1056/NEJMoa2102214 Singanayagam, 2022, Community transmission and viral load kinetics of the SARS-CoV-2 delta (B. 1.617. 2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study, Lancet Infect Dis, 22, 183, 10.1016/S1473-3099(21)00648-4 MacDonald, 2015, Vaccine hesitancy: definition, scope and determinants, Vaccine, 33, 4161, 10.1016/j.vaccine.2015.04.036 Tram, 2021, Deliberation, dissent, and distrust: understanding distinct drivers of COVID-19 vaccine hesitancy in the United States, Clin Infect Dis Razai, 2021, COVID-19 vaccination hesitancy, BMJ, 373, n1138, 10.1136/bmj.n1138 Machingaidze, 2021, Understanding COVID-19 vaccine hesitancy, Nat Med, 27, 1338, 10.1038/s41591-021-01459-7 Daly, 2021, Public trust and willingness to vaccinate against COVID-19 in the US from October 14, 2020, to March 29, 2021, JAMA, 325, 2397, 10.1001/jama.2021.8246 Wang, 2021, Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong, China: repeated cross-sectional surveys, Vaccines, 9, 62, 10.3390/vaccines9010062 Loomba, 2021, Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA, Nat Hum Behav, 5, 337, 10.1038/s41562-021-01056-1 Solís Arce, 2021, COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries, Nat Med, 27, 1385, 10.1038/s41591-021-01454-y Nomura, 2021, Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: a large cross-sectional national survey, Lancet Reg Health West Pac, 14 Wiysonge, 2022, Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?, Hum Vaccin Immunother, 18, 1, 10.1080/21645515.2021.1893062 Wong, 2021, Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong, Vaccine, 39, 1148, 10.1016/j.vaccine.2020.12.083 Woolf, 2021, Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: results from the UK-REACH prospective nationwide cohort study, Lancet Reg Health Eur, 9 Du, 2021, Pandemic fatigue impedes mitigation of COVID-19 in Hong Kong, Res Sq Cowling, 2010, Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong, J Infect Dis, 202, 867, 10.1086/655811 Leung, 2005, Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong, Clin Infect Dis, 40, 1713, 10.1086/429923 de Figueiredo, 2020, Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study, Lancet, 396, 898, 10.1016/S0140-6736(20)31558-0 Centre for Health Protection. Coronavirus disease (COVID-19) in HK. 2021. https://chp-dashboard.geodata.gov.hk/covid-19/en.html. Accessed 13 Sep 2021. The Government of the Hong Kong SAR. Government announces 2019 COVID-19 vaccination programme. 2021. https://www.info.gov.hk/gia/general/202102/18/P2021021800767.htm. Accessed 2 Nov 2021. The Government of the Hong Kong SAR. Suspension of BioNTech vaccination. 2021. https://www.info.gov.hk/gia/general/202103/24/P2021032400357.htm (accessed 10 Nov 2021). The Government of the Hong Kong SAR. LCQ17: COVID-19 vaccination programme. 2021. https://www.info.gov.hk/gia/general/202104/21/P2021042000643.htm?fontSize=1. Accessed 5 Dec 2021. Wang, 2021, The changing acceptance of COVID-19 vaccination in different epidemic phases in China: a longitudinal study, Vaccines, 9, 191, 10.3390/vaccines9030191 Prickett, 2021, COVID-19 vaccine hesitancy and acceptance in a cohort of diverse New Zealanders, Lancet Reg Health West Pac, 14 Zheng, 2020, Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis, J Infect, 81, e16, 10.1016/j.jinf.2020.04.021 Bajgain, 2021, Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature, Am J Infect Control, 49, 238, 10.1016/j.ajic.2020.06.213 Dodd RH, Pickles K, Cvejic E, et al. Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia. medRxiv 2021 Aug 5;S0264-410X(21)01008-2. doi: 10.1016/j.vaccine.2021.08.007. Online ahead of print. Ni, 2020, Depression and post-traumatic stress during major social unrest in Hong Kong: a 10-year prospective cohort study, Lancet, 395, 273, 10.1016/S0140-6736(19)33160-5 Krause, 2021, Considerations in boosting COVID-19 vaccine immune responses, Lancet, 398, 1377, 10.1016/S0140-6736(21)02046-8